AstraZeneca’s chief executive said on Friday the drugmaker had not overpromised on its ability to supply COVID-19 vaccines around the world, as he defended big cuts in deliveries that prompted a lawsuit by the European Union.
Pascal Soriot told a media briefing that the company did its best to deliver as much as it could to the EU.
“We never overpromised, we communicated what we thought we would achieve at the time,” he said.
AstraZeneca Q1 COVID-19 vaccine revenue hits $275 millionAstraZeneca said on Friday its COVID-19 vaccine contributed $275 million in sales and shaved off three cents per share from its first-quarter earnings ... Coronavirus
British medicine regulator cites 41 more blood clot reports following AstraZeneca jabBritain’s medicine regulator on Thursday said there had been a further 41 reports of rare blood clots after doses of AstraZeneca’s COVID-19 vaccine, ... Coronavirus
EU sues AstraZeneca for not respecting coronavirus vaccine supply contractThe European Commission said on Monday it had launched legal action against AstraZeneca for not respecting its contract for the supply of COVID-19 ... Coronavirus